Hemispherx Biopharma Inc (NYSE American:HEB)

0.3099
Delayed Data
As of 3:59pm ET
 -0.0321 / -9.39%
Today’s Change
0.28
Today|||52-Week Range
0.84
-10.43%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.34
Today’s open0.35
Day’s range0.28 - 0.35
Volume1,792,089
Average volume (3 months)673,096
Market cap$16.8M
Data as of 3:59pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+52.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-30.83%
P/E ratioNM
Price/Sales163.59
Price/Book0.73

Competitors

 Today’s
change
Today’s
% change
ITUSITUS Corp-0.20-5.17%
ARGSArgos Therapeutics I...----
----
ACHVAchieve Life Science...-0.03-2.26%
Data as of 4:00pm ET, 04/25/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$92.0K
Annual profit (last year)-$7.5M
Net profit margin-8,154.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Vice Chairman, President &
CEO
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Orlando, Florida

Forecasts